Healthcare Integrity & Anti-Fraud Enforcement
NCT07217730 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-10-17
Summary
The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.
Conditions
- Healthcare Fraud Schemes
- Kickback Networks
- Supply Chain Vulnerabilities
- Governance Failures
- Whistleblower Activation
- Regulatory Escalation Pathways
- Validator Oversight & DAO Governance
- Public Transparency & Auditability
Interventions
- OTHER
-
Validator-Governed Reform & Regulatory Escalation Protocol
This intervention deploys a validator-governed framework to monitor, escalate, and reform healthcare facilities exhibiting fraud, kickback schemes, and supply chain vulnerabilities. It integrates notarized affidavits, smart contract enforcement, NFT fiscal declarations, and DAO voting logic to trigger sanctions, regulatory complaints, and operational restructuring. Facilities are observed prospectively, with all actions logged to a public dashboard and anchored via SHA-256 hash notarization. No biospecimens are retained; all data is legal, technical, and governance-based.
- DEVICE
-
Coalition-Grade Validator Dashboard Module (CVDM-1)
The Coalition-Grade Validator Dashboard Module (CVDM-1) is a secure, web-based device deployed across enrolled healthcare facilities to enable real-time validator oversight, whistleblower affidavit intake, and smart contract enforcement. It integrates QR-linked audit trails, NFT fiscal declarations, and DAO voting logic. The device anchors all inputs via SHA-256 hash notarization and transmits reform metrics to coalition dashboards. CVDM-1 supports public transparency, regulatory escalation, and validator governance across the PHX-AFK-US Protocol. It does not collect biospecimens and operates solely within legal, technical, and governance domains.
- DRUG
-
Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1)
The Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1) is a governance-based drug intervention targeting facilities with suspected fraud, kickback schemes, or supply chain irregularities involving pharmaceuticals. While not a therapeutic agent, CFPAT-1 functions as a regulatory scaffold that flags drug procurement, formulary manipulation, and referral-linked prescribing patterns. It integrates validator ballots, smart contract logic, and SHA-256 hash anchors to escalate complaints to CMS, DOJ, and state boards. All flagged drugs are traced via QR-linked audit trails and NFT fiscal declarations. No biospecimens are retained; the intervention operates within legal, technical, and governance domains.
Sponsors & Collaborators
-
Truway Health, Inc.
lead INDUSTRY
Principal Investigators
-
Gavin C Solomon, President & CEO · Truway Health, Inc.
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-13
- Primary Completion
- 2034-10-13
- Completion
- 2034-10-13
Countries
- United States
Study Locations
More Related Trials
-
Measuring the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-centered Medical Home
NCT02077725 ·Status: WITHDRAWN
-
The Impact of Pharmaceutical Care on the Infection Control Measures Among Hemodialytic Patients
NCT06968754 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Informative Letters on the Prescription and Receipt of Opioids
NCT03202745 ·Status: WITHDRAWN ·Phase: NA
-
E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs
NCT06443385 ·Status: COMPLETED ·Phase: NA
-
Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services
NCT02752997 ·Status: COMPLETED ·Phase: NA
-
Rural Hospital-Level Care at Home for Acutely Ill Adults
NCT05256303 ·Status: COMPLETED ·Phase: NA
-
PLATO - Medication Adherence in Transplant Recipients
NCT04078750 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pharmacist-Led SDoH Screening Intervention During Transitions of Care in an Acute Care Setting
NCT06802393 ·Status: COMPLETED ·Phase: NA
-
Collaborative Home Visits to Reduce Hospital Readmissions and Improve Medication Use During Transitions of Care
NCT02087072 ·Status: WITHDRAWN
-
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
NCT02087293 ·Status: UNKNOWN ·Phase: NA
-
De-Implementation of Inappropriate Antimicrobial Use After Cardiac Device Procedures
NCT05020418 ·Status: COMPLETED ·Phase: NA
-
Rural Home Hospital: Proof of Concept
NCT04531280 ·Status: COMPLETED ·Phase: NA
-
Mobile Health Technology for Chronic Kidney Disease Patients: Medication Management
NCT02905474 ·Status: COMPLETED ·Phase: NA
-
Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD
NCT01459770 ·Status: COMPLETED ·Phase: NA
-
Impact of Vendor Systems on Ambulatory Medication Safety
NCT00773500 ·Status: COMPLETED
-
PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program
NCT03617380 ·Status: WITHDRAWN ·Phase: NA
-
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
NCT05351749 ·Status: COMPLETED ·Phase: NA
-
Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice
NCT01351441 ·Status: COMPLETED ·Phase: NA
-
Caregivers and Electronic Medication Monitoring in Chronic Kidney Disease
NCT01087255 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Deprescribing in a Long Term Care Facility
NCT03091153 ·Status: COMPLETED ·Phase: NA
-
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
NCT00632021 ·Status: COMPLETED ·Phase: NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
NCT06374277 ·Status: RECRUITING ·Phase: NA
-
Pharmacogenetic Testing Among Home Health Patients
NCT02378220 ·Status: COMPLETED ·Phase: NA
-
Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis Patients
NCT05952388 ·Status: WITHDRAWN ·Phase: NA
-
Multifaceted Intervention to Improve Prescribing in Patients With Chronic Kidney Disease
NCT00446615 ·Status: UNKNOWN ·Phase: NA